Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Madeline Cetlin"'
Autor:
Jorge Gómez Tejeda Zañudo, Sarah M Chu, Markella V. Zanni, Tonia Poteat, Mabel Toribio, Madeline Cetlin, Evelynne S Fulda, Karen Donelan
Publikováno v:
Transgender Health. 8:64-73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5e4139bbdca4d4b7a125bac55a74790
https://doi.org/10.1089/trgh.2021.0118
https://doi.org/10.1089/trgh.2021.0118
Autor:
Markella V. Zanni, Zsofia D. Drobni, Takara L. Stanley, Mabel Toribio, Michael Jerosch-Herold, Magid Awadalla, Tomas G. Neilan, Tricia H. Burdo, Evelynne S Fulda, Madeline Cetlin, Lidia S. Szczepaniak, Michael D. Nelson
Publikováno v:
J Acquir Immune Defic Syndr
OBJECTIVE: Women with HIV (WHIV) on antiretroviral therapy (ART) face an increased risk of cardiovascular disease (CVD) in the context of heightened systemic immune activation. Aortic stiffness, a measure of vascular dysfunction and a robust predicto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022d861faefd9b1b63ba39985118a407
https://doi.org/10.1097/qai.0000000000002419
https://doi.org/10.1097/qai.0000000000002419
Autor:
Evelynne S Fulda, Ole-Petter R. Hamnvik, Madeline Cetlin, Tonia Poteat, Markella V. Zanni, Mabel Toribio, Sarah M Chu
Publikováno v:
Current HIV/AIDS reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 18(5)
Transgender individuals are at disproportionate risk for HIV infection, with prevalence rates highest among transgender women of color. Antiretroviral therapy (ART)-treated people with HIV (PWH) are at increased risk for cardiovascular disease (CVD),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fdf6d1e96cad9ee23dfab91d20b17d
https://pubmed.ncbi.nlm.nih.gov/34626323
https://pubmed.ncbi.nlm.nih.gov/34626323
Autor:
Lidia S. Szczepaniak, Madeline Cetlin, Zsofia D. Drobni, Crystal M. North, Michael D. Nelson, Magid Awadalla, Evelynne S Fulda, Tricia H. Burdo, Markella V. Zanni, Tomas G. Neilan, Sarah M Chu, Michael Jerosch-Herold, Mabel Toribio, Sara E. Looby, Takara L. Stanley
Publikováno v:
Open Forum Infectious Diseases
Women with HIV (WWH) transitioning through menopause have heightened cardiovascular disease (CVD) risk. In the general population, hot flash burden relates to CVD risk indices. We found higher hot flash burden among women with vs without HIV. Further
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b935f25576b0b4a95ab1bc8a657a65c6
https://doi.org/10.1093/ofid/ofab011
https://doi.org/10.1093/ofid/ofab011
Autor:
Evelynne S Fulda, Mabel Toribio, Gregory K. Robbins, Markella V. Zanni, Madeline Cetlin, Tricia H. Burdo, Meghan N. Feldpausch, Steven K. Grinspoon, Tomas G. Neilan, Kathleen Melbourne, Sarah M Chu
Publikováno v:
Open Forum Infectious Diseases
The NOD-like receptor protein family pyrin domain containing 3 (NLRP3) inflammasome, activated in the setting of HIV, contributes to pro-atherogenic inflammation. Among antriretroviral therapy–naïve people with HIV (vs controls), levels of caspase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee59ee94f4ccc63c874635b92722d00d
http://europepmc.org/articles/PMC7588107
http://europepmc.org/articles/PMC7588107
Autor:
Evelynne S Fulda, Michael D. Nelson, Crystal M. North, Markella V. Zanni, Magid Awadalla, Zsofia D. Drobni, Lidia S. Szczepaniak, Madeline Cetlin, Tricia H. Burdo, Sara E. Looby, Takara L. Stanley, Mabel Toribio, Tomas G. Neilan, Michael Jerosch-Herold, Sarah M Chu
Publikováno v:
Journal of the Endocrine Society
Background: Women with HIV (WWH) (vs. women without HIV) have an increased risk of cardiovascular disease (CVD) in relation to heightened systemic immune activation/inflammation. Moreover, WWH show evidence of advanced reproductive aging and unique p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ed99833cc47672397cbf1fbb1aa08f
http://europepmc.org/articles/PMC8090309
http://europepmc.org/articles/PMC8090309